Scientists at EPFL in Lausanne have developed a semi-automated technology that may be a game-changer by making...
Up To Date
Backgrounds & Stories
To date, insurance business models have always been based on damage control, but that paradigm is changing....
90% of all preclinical drug candidates fail to make the grade. Now novel methods that employ miniaturised...
Over the last decade, therapeutic antibodies have fundamentally changed approaches in different areas of...
Only a small fraction of carefully selected patients are allowed to enroll in randomised controlled trials...
Disregarded for decades, extracellular vesicles are now understood to be a key element in communication...
Share
